244 related articles for article (PubMed ID: 17391982)
21. Negative regulation of lymphocyte development and function by the Cbl family of proteins.
Huang F; Gu H
Immunol Rev; 2008 Aug; 224():229-38. PubMed ID: 18759930
[TBL] [Abstract][Full Text] [Related]
22. Cbl-b and itch: key regulators of peripheral T-cell tolerance.
Venuprasad K
Cancer Res; 2010 Apr; 70(8):3009-12. PubMed ID: 20395198
[TBL] [Abstract][Full Text] [Related]
23. Cbl and Cbl-b in T-cell regulation.
Liu YC; Gu H
Trends Immunol; 2002 Mar; 23(3):140-3. PubMed ID: 11864842
[TBL] [Abstract][Full Text] [Related]
24. Cbl-b regulates airway mucosal tolerance to aeroallergen.
Oh SY; Park JU; Zheng T; Kim YK; Wu F; Cho SH; Barber D; Penninger J; Zhu Z
Clin Exp Allergy; 2011 Mar; 41(3):434-42. PubMed ID: 20738317
[TBL] [Abstract][Full Text] [Related]
25. Dysregulation of anergy-related factors involved in regulatory T cells defects in Systemic Lupus Erythematosus patients: Rapamycin and Vitamin D efficacy in restoring regulatory T cells.
Banica LM; Besliu AN; Pistol GC; Stavaru C; Vlad V; Predeteanu D; Ionescu R; Stefanescu M; Matache C
Int J Rheum Dis; 2016 Dec; 19(12):1294-1303. PubMed ID: 25351606
[TBL] [Abstract][Full Text] [Related]
26. Visualizing the role of Cbl-b in control of islet-reactive CD4 T cells and susceptibility to type 1 diabetes.
Hoyne GF; Flening E; Yabas M; Teh C; Altin JA; Randall K; Thien CB; Langdon WY; Goodnow CC
J Immunol; 2011 Feb; 186(4):2024-32. PubMed ID: 21248249
[TBL] [Abstract][Full Text] [Related]
27. Deltex1 promotes protein kinase Cθ degradation and sustains Casitas B-lineage lymphoma expression.
Hsu TS; Hsiao HW; Wu PJ; Liu WH; Lai MZ
J Immunol; 2014 Aug; 193(4):1672-80. PubMed ID: 25000980
[TBL] [Abstract][Full Text] [Related]
28. Cbl-b regulates the CD28 dependence of T-cell activation.
Chiang YJ; Kole HK; Brown K; Naramura M; Fukuhara S; Hu RJ; Jang IK; Gutkind JS; Shevach E; Gu H
Nature; 2000 Jan; 403(6766):216-20. PubMed ID: 10646609
[TBL] [Abstract][Full Text] [Related]
29. Deltex1 is a target of the transcription factor NFAT that promotes T cell anergy.
Hsiao HW; Liu WH; Wang CJ; Lo YH; Wu YH; Jiang ST; Lai MZ
Immunity; 2009 Jul; 31(1):72-83. PubMed ID: 19592273
[TBL] [Abstract][Full Text] [Related]
30. Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.
Wohlfert EA; Gorelik L; Mittler R; Flavell RA; Clark RB
J Immunol; 2006 Feb; 176(3):1316-20. PubMed ID: 16424156
[TBL] [Abstract][Full Text] [Related]
31. Spontaneous tumor rejection by cbl-b-deficient CD8+ T cells.
Loeser S; Loser K; Bijker MS; Rangachari M; van der Burg SH; Wada T; Beissert S; Melief CJ; Penninger JM
J Exp Med; 2007 Apr; 204(4):879-91. PubMed ID: 17403934
[TBL] [Abstract][Full Text] [Related]
32. Egr-2 and Egr-3 are negative regulators of T cell activation.
Safford M; Collins S; Lutz MA; Allen A; Huang CT; Kowalski J; Blackford A; Horton MR; Drake C; Schwartz RH; Powell JD
Nat Immunol; 2005 May; 6(5):472-80. PubMed ID: 15834410
[TBL] [Abstract][Full Text] [Related]
33. Negative regulation of CD40-mediated B cell responses by E3 ubiquitin ligase Casitas-B-lineage lymphoma protein-B.
Qiao G; Lei M; Li Z; Sun Y; Minto A; Fu YX; Ying H; Quigg RJ; Zhang J
J Immunol; 2007 Oct; 179(7):4473-9. PubMed ID: 17878343
[TBL] [Abstract][Full Text] [Related]
34. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation.
Watanabe Y; Sasahara Y; Ramesh N; Massaad MJ; Yeng Looi C; Kumaki S; Kure S; Geha RS; Tsuchiya S
J Allergy Clin Immunol; 2013 Sep; 132(3):648-655.e1. PubMed ID: 23684068
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte signaling: Cbl sets the threshold for autoimmunity.
Rudd CE; Schneider H
Curr Biol; 2000 May; 10(9):R344-7. PubMed ID: 10801434
[TBL] [Abstract][Full Text] [Related]
36. Control of virus-specific CD8+ T-cell exhaustion and immune-mediated pathology by E3 ubiquitin ligase Cbl-b during chronic viral infection.
Ou R; Zhang M; Huang L; Moskophidis D
J Virol; 2008 Apr; 82(7):3353-68. PubMed ID: 18199651
[TBL] [Abstract][Full Text] [Related]
37. Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation.
Tran CW; Saibil SD; Le Bihan T; Hamilton SR; Lang KS; You H; Lin AE; Garza KM; Elford AR; Tai K; Parsons ME; Wigmore K; Vainberg MG; Penninger JM; Woodgett JR; Mak TW; Ohashi PS
J Immunol; 2017 Dec; 199(12):4056-4065. PubMed ID: 29109121
[TBL] [Abstract][Full Text] [Related]
38. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells.
Fang D; Liu YC
Nat Immunol; 2001 Sep; 2(9):870-5. PubMed ID: 11526404
[TBL] [Abstract][Full Text] [Related]
39. Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance.
Schartner JM; Fathman CG; Seroogy CM
Semin Immunol; 2007 Jun; 19(3):188-96. PubMed ID: 17403607
[TBL] [Abstract][Full Text] [Related]
40. Casitas b cell lymphoma‑B (Cbl-b): A new therapeutic avenue for small-molecule immunotherapy.
Hu X; Li E; Zhou Y; You Q; Jiang Z
Bioorg Med Chem; 2024 Mar; 102():117677. PubMed ID: 38457911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
